<DOC>
	<DOCNO>NCT02732990</DOCNO>
	<brief_summary>Exercise intolerance major limit symptom patient CHF . However poor correlation hemodynamic parameter leave ventricular performance rest exercise performance lead concept peripheral factor muscle perfusion muscle metabolism play role determinant exercise capacity .</brief_summary>
	<brief_title>Peripheral Metabolic Function Chronic Heart Failure Patients</brief_title>
	<detailed_description>The pathophysiology behind breathlessness fatigue experience CHF patient exercise remain unclear . Recent evidence suggest peripheral skeletal muscle , become abnormal heart failure , source afferent signal disrupt normal pattern cardiorespiratory control . When CHF patient exercise , inappropriately strong sympathetic response limit exercise tolerance evoke large normal increase peripheral sympathetic activation faster rate healthy individual . A consequence exacerbate sympathetic response may sympathetic restraint blood flow active skeletal muscle result hypoperfusion muscle vascular bed fatigue . Small muscle mass exercise training increase muscle oxidative capacity improve aerobic work capacity CHF patient . A range study propose provide integrative view mechanistic basis behind exercise intolerance CHF relate intramuscular metabolic status autonomic control hemodynamics exercise . An understanding mechanistic basis improve exercise tolerance training , independent improve rest cardiac function , yield important information regard integrate control blood flow metabolic demand CHF highlight importance maintain integrity peripheral musculature CHF .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>New York Heart Association ( NYHA ) Class II III Ejection fraction &lt; 35 % Heart failure result previous myocardial infarction Optimal treatment ( ACEinhibitors , betablockers ) Stable heart failure Patients without implantable cardioverter defibrillator ( ICD ) Peripheral vascular disease symptom atherosclerosis ( intermittent claudication ) Aneurysm a. femoral Moderate severe heart valve disease Moderate severe Chronic Obstructive Pulmonary Disease ( COPD ) FEV1 &lt; 60 % Heart Failure Patients Biventricular pacemaker ( BVP ) Serious heart rhythm disturbance ( arrhythmias atrial fibrillation frequent premature ventricular contraction ) Myocardial infarction within last month Unstable angina ( angina pectoris ) Renal failure ( creatinine great 2.5 mg / dL ) Severe systemic disease nervous system , pulmonary severe organ involvement BMI &gt; 30 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Training</keyword>
	<keyword>One-legged exercise</keyword>
	<keyword>Peripheral blood flow</keyword>
	<keyword>Cardiac function</keyword>
	<keyword>Muscle metaboreflex</keyword>
</DOC>